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Purpose: PTW’s Octavius 1000 SRS array performs IMRT quality assurance (QA) measurements
with liquid-filled ionization chambers (LICs) to allow closer detector spacing and higher resolution,
compared to air-filled QA devices. However, reduced ion mobility in LICs relative to air leads to
increased ion recombination effects and reduced collection efficiencies that are dependent on Linac
pulse frequency and pulse dose. These pulse parameters are variable during an IMRT delivery, which
affects QA results. In this study, (1) 1000 SRS collection efficiencies were measured as a function
of pulse frequency and pulse dose, (2) two methods were developed to correct changes in collection
efficiencies during IMRT QA measurements, and the effects of these corrections on QA pass rates
were compared.
Methods: To obtain collection efficiencies, the OCTAVIUS 1000 SRS was used to measure open
fields of varying pulse frequency, pulse dose, and beam energy with results normalized to air-filled
chamber measurements. Changes in ratios of 1000 SRS to chamber measured dose were attributed
to changing collection efficiencies, which were then correlated to pulse parameters using regression
analysis. The usefulness of the derived corrections was then evaluated using 6 MV and 10FFF SBRT
RapidArc plans delivered to the OCTAVIUS 4D system using a TrueBeam (Varian Medical Systems)
linear accelerator equipped with a high definition multileaf collimator. For the first correction, 
software was developed that calculates pulse frequency and pulse dose for each detector, using
measurement and DICOM RT Plan files. Pulse information is converted to collection efficiency,
and measurements are corrected by multiplying detector dose by ratios of calibration to measured
collection efficiencies. For the second correction the MU/min in the daily 1000 SRS calibration was
chosen to match the average MU/min of the volumetric modulated arc therapy plan. Effects of the two
corrections on QA results were examined by performing 3D gamma analysis comparing predicted to
measured dose, with and without corrections.
Results: Collection efficiencies correlated linearly to pulse dose, while correlations with pulse
frequency were less defined, generally increasing as pulse frequency decreased. After complex
 corrections, average 3D gamma pass rates improved by [0.07%,0.40%,1.17%] for 6 MV and
[0.29%,1.40%,4.57%] for 10FFF using [3%/3 mm,2%/2 mm,1%/1 mm] criteria. Maximum changes
in gamma pass rates were [0.43%,1.63%,3.05%] for 6 MV and [1.00%,4.80%,11.2%] for 10FFF
using [3%/3 mm,2%/2 mm,1%/1 mm] criteria. On average, pass rates of simple daily calibration
corrections were within 1% of complex  corrections.
Conclusions: OCTAVIUS 1000 SRS ion recombination effects have little effect on 6 MV measure-
ments. However, the effect could potentially be clinically significant for higher pulse dose unflattened
beams when using tighter gamma tolerances, especially when small aperture sizes are used, as is
common for SRS/SBRT. In addition, ion recombination effects are strongly correlated to changing
MU/min, therefore MU/min used in daily 1000 SRS calibrations should be matched to the expected
average MU/min of the IMRT plan. C 2016 American Association of Physicists in Medicine.
[http://dx.doi.org/10.1118/1.4946822]
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1. INTRODUCTION
IMRT quality assurance (QA) consists of delivering patient
plans to dosimetric measuring devices and comparing the dose
to that predicted by the treatment planning system (TPS).
The devices must accurately measure dose with high enough
resolution to sufficiently characterize the field. When small
field sizes are used this requires the close placement of small
detectors.1,2 This can cause issues when using air-filled ioni-
zation chambers, typically used in nonIMRT radiation dose
measurements.3,4 The low-density air results in less scatter and
a low signal to noise ratio, which limits the proximity and size
of the detectors.
One potential solution is to use liquid-filled ionization
chambers (LICs), which use higher-density liquid to increase
response and scatter.5,6 However, there is a tradeoff—the liquid
reduces ion mobility, leading to ion collection times that
are approximately 100 times larger than air-filled chambers,
which increases ion recombination effects.7–13 Ion recombi-
nation effects have been studied in LICs and found to be
proportional to the frequency and dose of the pulses delivered
to the detector, among other parameters that are typically
constant during a measurement. The dose and frequency of
the pulses at each detector will vary during an IMRT delivery
due to the changing multileaf collimator (MLC) aperture and
changing machine dose rate (MU/min), respectively. This
could potentially introduce ion recombination effects into QA
measurements, resulting in a distortion of the dose map and
overall IMRT QA results.
The PTW 1000 SRS array (PTW, Freiburg, Germany)
implements the above described LICs, for small field IMRT
measurements.14 The goal of this research is to determine the
effect of ion recombination on clinical 1000 SRS volumetric
modulated arc therapy (VMAT) QA measurements and inves-
tigate two potential ion recombination correction methods.
2. MATERIALS AND METHODS
The device used in this study is the 1000 SRS detector.
The 1000 SRS detector consists of 977 isooctane-filled LICs.
The chambers have dimensions 2.3× 2.3× 0.5 mm (depth).
The chambers are arranged in a planar array with a spacing of
2.5 mm in the center of the array and 5.0 mm at the periphery
(Fig. 1). During measurements the array was placed in a rotat-
ing Octavius 4D phantom, which uses an inclinometer to keep
the array aligned perpendicular to the axis of the beam.15 All
measurements were performed on a TrueBeam linear acceler-
ator (Varian Medical Systems, Pal Alto, CA) equipped with a
high definition multileaf collimator (HD-MLC).
2.A. LIC ion recombination
The evaluation of the 1000 SRS detector began by deter-
mining the correlation between collection efficiency and pulse
dose for the 1000 SRS LICs in 6 MV and 10FFF beams.
This investigation consisted of exposing the 1000 SRS de-
tector to different pulse dose rates, measuring the dose and
comparing the results to true dose measured with a 0.125 cm2
F. 1. 1000 SRS detector locations. Detectors are 2.3 mm wide squares.
Centroid spacing is 2.5 mm in the center and 5.0 mm in the peripheral.
model 31010 air-filled ionization chamber (PTW, Freiburg,
Germany) to determine the LIC collection efficiencies.
To create a consistent setup where the 1000 SRS detector
measured the same pulse dose as the ion chamber, the detectors
were alternately placed at the same location in a solid water
stack. Prior to measurements, both devices were preirradi-
ated, per manufacturer recommendations. After preirradiation,
9.1 cm of solid water was placed on top of the 1000 SRS—
combined with the 0.9 cm buildup in the device this resulted
in an equivalent depth of 10 cm. The distance to the surface
of the solid water, or source-to-phantom distance (SPD), was
set to 100 cm. Using a 10 × 10 cm field, 100 MUs were
delivered to the 1000 SRS with the maximum dose rate of
600 and 2400 MU/min for 6 MV and 10FFF, respectively.
For subsequent measurements, the SPD and buildup on top of
the 1000 SRS were varied to produce different pulse doses at
the detectors. For each SPD and depth combination, the 1000
SRS dose measurement was divided by the ion chamber charge
reading, which was corrected for Ptp, Ppol, and Pion using TG51
formalisms.16 These ratios were subsequently normalized to
the dose/charge ratio at 100 cm SPD and 10 cm depth. The
change in the dose/charge ratio at each SPD/depth combina-
tion was attributed to the different collection efficiencies of the
LICs caused by the different pulse doses.
To correlate the LIC collection efficiencies with pulse dose,
the pulse dose at the 1000 SRS central chamber was calculated
for each SPD. The dose and number of pulses were determined
separately and then used to calculate pulse dose. First, dose
was obtained for 100 cm SPD by simulating the delivery
in the Eclipse TPS (Varian Medical Systems, Pal Alto, CA)
and calculating dose to the center detector. To eliminate any
potential dosimetric effects caused by calculating dose in the
treatment planning system at different SPDs, the ratios of the
corrected ionization chamber readings were used to convert
dose at 100 cm SPD to dose at other SPDs.
The number of pulses was determined from the pulse
repetition frequency of the Linac and the delivery time. The
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deliveries were performed at the maximum MU/min (600
and 2400 MU/min for 6X and 10FFF, respectively), which
corresponds to a Linac pulse frequency of 360 Hz. Pulse
frequency and calculated dose to the 1000 SRS detector were
used to calculate pulse dose at each SPD.
The collection efficiencies were plotted against the pulse
dose for different SPDs to obtain the pulse dose dependency
of the 1000 SRS detector central chamber. The plotted data
were modeled using a linear least-square fitting method. Based
on the fitting results, a constant was subtracted from all of
the collection efficiency data so that the modelled collection
efficiency was 1.0 for a 0.0 mGy/pulse rate.
To study the effect of pulse frequency on collection effi-
ciency, the above procedure was repeated with different
MU/min. The set MU/min values were used to calculate
average pulse frequency using the linear correlation between
the two parameters and the fact that the max MU/min corre-
sponded to a 360 Hz pulse frequency.
2.B. IMRT ion recombination corrections
The following is a brief description of how the 1000 SRS
is used in the Octavius 4D system for clinical IMRT QA
measurements. 1000 SRS measurements are performed in the
Octavius 4D system, which consists of a rotating phantom that
keeps the array perpendicular to the beam using an inclinom-
eter attached to the gantry. Prior to a QA measurement, the
central chamber of the 1000 SRS is calibrated to a known dose
using a reference beam from the Linac. A default Co-60 array
calibration file, included with the device, has chamber-specific
calibration factors, which are scaled using the daily central
chamber calibration, thereby calibrating the whole array. Once
calibrated, treatment fields are delivered to the 1000 SRS,
which measures dose in user defined collection intervals (0.2 s
for this study) as a function of gantry angle. For each collection
interval, a vendor-supplied analysis software (VeriSoft) takes
the measured dose and uses PDDs to back-project a 3D dose
throughout the Octavius 4D phantom. The total dose, from
all collection intervals, is combined and compared to the TPS
using a 3D gamma analysis.17,18
The daily 1000 SRS calibration is performed at a depart-
ment specific standard pulse frequency and pulse dose. Dur-
ing a 1000 SRS measurement, the changing MU/min and
MLC aperture will cause the pulse frequency and dose to vary
across the detector, which will cause changes in the collection
efficiency. The changing collection efficiency could poten-
tially cause errors in the IMRT QA measurement. To deter-
mine the magnitude of this effect the collection efficiencies
determined in Subsection 2.A were used to correct clinical
1000 SRS measurements. The details of the IMRT measure-
ments, the corrections, and the IMRT analysis are presented in
Subsections 2.C–2.E.
2.C. VMAT measurements
The effects of ion recombination were studied in seven clin-
ical SBRT plans: four lung, two spine, and one liver plan. The
number of available clinical lung SBRT cases far outweighed
spine and liver cases; however, a variety of plans were chosen
to provide a broad case-set for studying ion recombination
effects. All plans used RapidArc deliveries. All of the plans
were replanned on the same machine (TrueBeam) for both
6 MV and 10FFF energies, using the original clinical dose
objectives specified by the physician and a 1.5 mm calculation
voxel size, per department protocol. Each plan consisted of
4 or 6 arcs. In total, 34 arcs were measured for each en-
ergy. Each arc was delivered individually to the Octavius 4D.
The measured dose was compared to the dose calculated in
the TPS using a 3D gamma analysis. In this work the 3D
gamma analysis was performed with a 3%/3 mm, 2%/2 mm,
and 1%/1 mm global criteria using a threshold that excluded
measurements below 10% of the maximum calculated TPS
dose. Finally, the measurements were corrected for ion recom-
bination effects using the procedures in Sec. 2.D, and then
reanalyzed.
2.D. Measurement corrections
Ion recombination effects in 1000 SRS measurements are
caused by the difference in collection efficiencies between the
daily array calibration and the IMRT delivery. To correct this
effect in the 1000 SRS measurements, the pulse frequencies
and pulse dose for both calibration and the IMRT measure-
ment were calculated. The pulse information was used to find
collection efficiencies using the measured relationships from
Sec. 2.A. Finally, the ratios of calibration/measured collection
efficiencies were used as correction factors for the 1000 SRS
measurements.
First, the pulse dose during 1000 SRS calibration was calcu-
lated. The dose to the central chamber was calculated from the
TPS. The number of pulses was calculated from the MU/min
of the machine and the delivery time (360 Hz when using the
maximum MU/min).
Pulse frequency and dose during a measurement were
calculated using the 1000 SRS measurement file and data from
the TPS. The formula for determining the pulse dose during
a measurement is shown in Eq. (1). This formula assumes
a constant pulse dose throughout the individual collection
intervals of the Octavius 4D, which was set to 0.2 s for all of the
measurements. This limitation in temporal resolution makes it
difficult, if not impossible to distinguish separate pulses—only
the average pulse frequency during the collection interval is
obtainable. As such, Eq. (1) does not calculate the actual pulse
dose, rather it will calculate the average pulse dose during the
0.2 s collection interval.
Furthermore, the dose rate servo of the TrueBeam may
modulate the pulse structures (height and width) to modu-
late dose rate. This correction technique assumes a change in
collection efficiency due to increasing pulse frequency with
increasing dose rate; however, the decrease in collection effi-
ciency due to frequency increase may not match the decrease
in collection efficiency due to a change in pulse structure. This
is an inherent limitation in this correction technique, which
warrants the additional investigation of a simpler correction
method.
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Dosemeasured is the amount of dose measured by each cham-
ber during a single sampling time. MU/minmeasured is the
MU/min of the machine during the sampling interval.
MU/minmax is the maximum MU/min of the machine for each












The Dosemeasured was taken directly from the Octavius 4D
measurement files.
The MU/minmeasured was found using information from the
measurement file and the TPS. The TPS stores a table con-
taining MU/min as a function of gantry angle. For each plan,
the MU/min vs gantry angle table was exported from the TPS
into the  software. The Octavius 4D system records
the gantry angle for each measurement point, which was used
to look up the MU/minmeasured from the TPS table. Planned
MU/min was used instead of the delivered MU/min due to
the uncertainty in the Octavius 4D inclinometer reading that
resulted in unrealistic pulse doses when measurements were
matched with the delivered MU/min from the beam trajec-
tory files. Using the planned MU/min resulted in more real-
istic pulse doses, especially when there were large changes in
MU/min as a function of gantry angle.
Using the data from the previous paragraphs and Eq. (1),
the pulse frequency and dose at every detector were found for
each measurement point. The pulse information was used to
calculate collection efficiencies via the measured relationships
from Subsection 2.A. Due to the low resolution of the collec-
tion efficiency vs frequency data (Fig. 3), linear interpolation
was used to calculate collection efficiencies for frequencies
that were not multiples of 60 Hz (MU/min not multiples of 100
and 400 MU/min for 6X and 10FFF, respectively). The collec-
tion efficiencies were used to determine correction factors for
each measurement point. Correction factors, shown in Eq. (2),
were the ratios of the collection efficiency at the time of daily






Each measurement point was subsequently multiplied by its
corresponding correction factor.
This correction method provides corrections for changes
in both pulse frequency and dose. However, the correction
method is cumbersome and may not be easily implemented
in standard QA practices. Therefore a second correction was
tested that involved simply matching the 1000 SRS daily cali-
bration MU/min to the expected average MU/min of the plan.
For simplicity the daily calibration correction will be referred
to as the “simple” correction, whereas the  correction
will be referred to as the “complex” correction.
The simple correction only accounts for changes in pulse
frequency and as such was expected to be less accurate than
the complex correction for changes in pulse frequency and
dose. To determine the accuracy of the simple corrections, the
resulting QA pass rates were compared for both correction
techniques.
One issue with the simple correction method is that the
TrueBeam linear accelerator only allows the selection of
discrete MU/min values during 1000 SRS calibration, making
it impossible to exactly match the calibration MU/min to that
of the plan. Therefore, a clinical user may have to choose a
calibration MU/min that is higher or lower than the plan. To
determine whether this choice has a major effect on QA results,
the effect of both high and low MU/min corrections was tested
and the resulting QA pass rates were compared.
2.E. VMAT analysis
After applying the correction factors to the measurements,
the Octavius 4D measurements were analyzed in the VeriSoft
software package. VeriSoft uses PDDs to project the measured
dose from the 1000 SRS throughout the phantom. Dose from
each projection is summed and compared to the dose predicted
by the TPS using a 3D gamma analysis. In this work, 3%/3 mm,
2%/2 mm, and 1%/1 mm global criteria were used with a 10%
threshold. In total seven patients were analyzed, with two plans
per patient (6X and 10FFF), for a total of 34 arcs per energy.
For each arc, an analysis was performed with and without pulse
dose corrections and the differences in gamma pass rates were
calculated.
To correlate the change in gamma pass rates with plan
parameters, the average MU/min and average MLC aperture
size were calculated for each arc. DICOM RT plan files were
imported into , where the MLC positions and meterset
weights were used to calculate the average aperture size for
each arc. Planned MU/min and meterset weights taken from
the DICOM files were used to calculate average MU/min.
The per-arc parameters were compared to the average change
in 1%/1 mm gamma pass rate for each plan using a linear
regression analysis, and Pearson correlation coefficients were
calculated.
3. RESULTS
Figure 2 shows the collection efficiency of the 1000 SRS
LICs for 6 MV and 10FFF, averaged over four days. Uncer-
tainties in measured collection efficiencies were less than 2.0
× 10−3 for both energies. Uncertainties tended to increase
for lower pulse doses (higher collection efficiencies) due to
lower 1000 SRS signal detection for a given MU. The results
are presented without error bars for clarity; however, the
uncertainty of the measurements are included in the slope
uncertainties shown in Fig. 3. The collection efficiencies were
linearly correlated with pulse dose. As expected, collection
efficiencies increased as both pulse dose and pulse frequency
decreased. The change in collection efficiencies as a function
of pulse dose were slightly larger for 10FFF, changing by
5.01%/(mGy/pulse) at 360 Hz (2400 MU/min), compared to
4.44%/(mGy/pulse) for 6X, when a 360 Hz (600 MU/min)
pulse frequency was used.
The magnitude of the slopes from the collection efficiency
versus pulse dose regression analysis is plotted against pulse
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F. 2. 1000 SRS liquid-filled ionization chamber collection efficiencies as
a function of pulse dose and pulse frequencies delivered to the detector for
(a) 6 MV and (b) 10FFF.
frequency in Fig. 3. Error bars in Fig. 3 are the calculated stan-
dard deviations of slope measurements, which were repeated
over multiple days. The slope magnitudes were used in the
ion recombination corrections to find the change in collection
efficiencies for measurements with different combinations of
pulse dose and pulse frequency.
3.A. VMAT analysis
The change in 3D gamma pass rates from the ion recom-
bination corrections is shown in Table I for 6 MV and 10FFF.
For all fields, pass rates improved after corrections. For each
plan, the changes in pass rates were averaged over all arcs.
The per-plan change in pass rates, found by averaging the pass
rate changes for all arcs in a single plan, was used to calculate
average (Avg.), maximum (Max.), and standard deviation (σ).
Simple corrections produced pass rates both larger and
smaller than complex corrections. To quantify the difference
F. 3. Magnitude of ion recombination effects as a function of pulse fre-
quency. All measurements are for multiples of 60 Hz (100 MU/min for 6X
and 400 MU/min for 10FFF)—they have been offset for improved visualiza-
tion. The vertical axis is the change in ion collection efficiency for a given
change in pulse dose.
in pass rates between the two correction methods, the absolute
difference in per-arc pass rates was calculated and the results
are shown in Table II. During simple corrections the nearest
possible calibration MU/min was selected to match the plan.
Both the results for rounding up (High) and rounding down
(Low) to the nearest MU/min are displayed. On average the
direction of rounding had less than a 0.5% effect on pass rates.
However, selection of the lower calibration MU/min produced
pass rates closer to the complex corrections.
Figure 4 shows dose profiles displaying the effects of ion
recombination corrections for a single arc. The dose profile is
taken along the C/A of the detector. The profiles are truncated
below 10% of the maximum dose, to show the measurements
that will be included in the gamma analysis. The uncorrected
(measured) and corrected dose planes are compared to the dose
predicted by the TPS. The difference between measured and
corrected dose has been plotted as an absolute difference (M
−C) and a relative difference ((M−C)/M∗100%). The relative
distance represents the magnitude of the ion recombination
corrections at those detector locations.
Figure 5 shows the average per-plan change in pass rates
due to recombination corrections plotted against average
planned MLC aperture size and average MU/min. The equa-
tions from the linear regression are shown on the plots along
with the Pearson correlation coefficients. Changes in pass
rates were weakly correlated to average MLC aperture size;
however, they tended to increase as smaller aperture sizes were
used. Changes in pass rates were more strongly correlated to
MU/min, increasing as average MU/min decreased.
4. DISCUSSION
The linearity between collection efficiency and pulse dose,
shown in Fig. 2, matches the relationships found by Chung
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T I. Changes in gamma pass rates from complex ion recombination corrections. The average (Avg.), standard
deviation (σ), and maximum (Max.) changes were calculated from the per-plan changes in pass rates.
3D gamma pass rate changes
3%/3 mm 2%/2 mm 1%/1 mm
Energy Avg. σ Max. Avg. σ Max. Avg. σ Max.
6X 0.07 0.16 0.43 0.40 0.66 1.63 1.17 1.14 3.05
10FFF 0.29 0.40 1.00 1.40 2.09 4.80 4.57 3.71 11.20
et al.8 The magnitude of the slope of the 6 MV linear fits was
4.44%/(mGy/pulse) for 360 Hz (600 MU/min). The slope was
close to the manufacturer quoted values of 3.79%/(mGy/pulse)
compared to previous publications that found slopes closer to
10.0%/(mGy/pulse) for the 1000 SRS.14,19 The difference in
measured collection efficiencies from previous publications
may be due to the different pulse frequency (400 vs 360 Hz)
and measurement technique (two-dose rate method vs ion
chamber normalization), used in the other studies.
It is important to note that the measured collection effi-
ciencies are specific to the TrueBeam’s pulse structure. When
operating at the maximum dose rate, the TrueBeam delivers
radiation in bundles of 6 equally spaced pulses. When a
lower dose rate is used, pulses are dropped. However, the
remaining pulses are not uniformly distributed in the bundles.
The longer collection time in the Octavius 4D measurements,
0.2 s spanning 12 bundles, will provide some averaging against
the pulse nonuniformity. However, the collection efficiencies
shown in Fig. 2 will still be unique to the nonuniform pulse
sequence of the TrueBeam and may not be applicable to other
pulse structures.
The pulse structure of the TrueBeam can help explain the
change in ion recombination slopes for the different pulse
frequencies, shown in Figs. 2 and 3. Chung et al. described the
difference in the ion recombination slopes between, pulsed and
continues beams.8 The slopes of the continuous beams were
steeper than the pulsed slopes. This was due to the buildup
of free charge in the chamber, which will increase general
recombination, resulting in a higher ion recombination effect.
Figure 3 shows the magnitude of ion recombination
decreasing as pulse frequency decreases. When the TrueBeam
is operating at the highest dose rate and frequency, the pulse
sequence will be closest to a continuous beam. As the dose
rate is lowered, pulses are dropped, reducing the buildup of
free charge, resulting in a more discontinuous beam and lower
slope. Uncertainties in ion recombination magnitudes were
primarily due to uncertainties in (1) measuring Pion, (2) 1000
SRS measurements, and (3) the linear regression analysis.
Uncertainties in the 6X ion recombination magnitudes were
typically larger than 10FFF, due to the increased collection of
leakage in longer (lower MU/min) 1000 SRS measurements.
4.A. VMAT analysis
The effects of ion recombination corrections on pass rates
were larger for 10FFF compared to 6X. The larger changes
in pass rates were caused by three differences: (1) the pulse
dose at the central axis of the 1000 SRS in Octavius 4D
was larger for 10FFF (0.760 mGy/pulse) compared to 6 MV
(0.175 mGy/pulse), (2) as seen in Fig. 3, a change in pulse dose
results in a larger change in collection efficiency for 10FFF,
and (3) as seen in Fig. 5, the average MU/min of 10FFF plans
deviated further from calibration (max MU/min), compared
to 6 MV. Changes in pass rates, due to ion recombination
corrections, increased with tighter gamma analysis criteria.
Tighter gamma criteria have been recommended for SBRT QA
(2%/1 mm or less), due to the high conformity, small field size,
and hypofractionation of SBRT treatments.20,21 Therefore, the
tighter gamma criteria, where ion recombination corrections
are the largest, will likely be used in a clinical analysis.
Ion recombination corrections tend to have a uniform ef-
fect on the VMAT dose distribution. As seen in Fig. 4, the
magnitude of the ion recombination effect ((M−C)/M∗100%)
is mostly uniform in the high dose region (>10% max dose).
There is some nonuniformity in the high dose regions near the
high dose gradients of the profiles. During a VMAT delivery,
the high dose gradients are created by exposing a MLC edge
at that location, which results in a dosimetric penumbra with a
T II. Comparison of the 3D gamma pass rate results obtained after simple and complex ion recombination
corrections. The average (Avg.), standard deviation (σ), and maximum (Max.) changes were calculated from the
absolute values of per-arc changes in pass rates.
Pass rate difference between correction methods
3%/3 mm 2%/2 mm 1%/1 mm
Energy MU/min Avg. σ Max. Avg. σ Max. Avg. σ Max.
6X
High 0.03 0.05 0.1 0.21 0.19 0.5 0.78 0.30 1.2
Low 0.01 0.02 0.0 0.10 0.06 0.2 0.43 0.28 0.7
10FFF
High 0.01 0.02 0.0 0.27 0.16 0.5 0.98 0.58 2.2
Low 0.00 0.01 0.0 0.18 0.08 0.3 0.80 0.42 1.7
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F. 4. Dosimetric effects of complex ion recombination corrections in the
coronal plane of the Octavius 4D phantom. (a) Measured and ion recombina-
tion corrected dose profiles along the central axis of the 1000 SRS compared
to the TPS predicted dose. (b) Difference between measured and corrected
profiles. The relative distance is plotted on the right vertical axis.
spatially varying pulse dose. The change in pulse dose from
the calibration conditions is the cause of the increased ion
recombination effects at these locations.
Although there is some nonuniformity in ion recombination
effects across a VMAT field, the effect tends to be uniform in
the high dose region (>10% max dose)—the region that will
be included in the VMAT analysis. Across the subset of LICs
measuring in the high-dose region of a VMAT distribution, ion
recombination corrections tend to be uniform within the subset
and dependent upon rep-rate only due to the majority of the
dose being delivered to these chambers directly through open
MLC apertures at similar pulse doses. The uniformity of ion
recombination effects is expected to be similar for static-gantry
IMRT and nonSBRT deliveries, given similar conditions of
uniform pulse doses within the high dose region of the field.
This uniformity of the ion recombination effect is promising,
in that it may be possible to apply a single calibration factor,
F. 5. Correlation between changes in 3D gamma analysis pass rates (∆PRs)
from pulse dose corrections and (a) average MLC aperture size (AS),
(b) average MU/min (RR). 3D gamma analysis was performed using a
1%/1 mm criteria with a 10% dose threshold.
which could account for this effect. The daily calibration of
the 1000 SRS presents itself as a natural opportunity for the
application of a global calibration factor to account for ion
recombination.
The inclusion of an ion recombination correction in the
daily calibrations requires an identification of the magni-
tude of recombination prior to delivery. For this reason, the
magnitudes of the ion recombination effects were correlated
to average planned MU/min and aperture size—parameters
that will change pulse frequency and pulse dose, respectively.
Figure 5 shows the results of this investigation, where it was
found that the magnitudes of ion recombination effects are
more strongly correlated to MU/min.
The stronger correlation suggests that the magnitudes of
the ion recombination effects in the 1000 SRS measurements
are larger for changes in MU/min, rather than MLC aperture
size. The reasoning for the increased effect can be discerned
from the measurement and the process used to calibrate the
1000 SRS. The magnitudes of the dosimetric errors due to the
ion recombination effect at any point in the measurement are
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equal to the change in collection efficiency multiplied by the
dose per pulse. The 1000 SRS was calibrated at the maximum
pulse dose and pulse frequency. Lowering the pulse frequency
(MU/min) will change the collection efficiency, while keeping
pulse dose larger, resulting in a large ion recombination effect.
Lowering the pulse dose (MLC aperture size) will change the
collection efficiency; however, there will be a smaller dosi-
metric error compared with the change in frequency. It is this
characteristic of the ion recombination effects that results in
larger dosimetric errors for changing frequency (MU/min).
Fortunately, ion recombination corrections for changing
MU/min can easily be included in the daily calibration by
matching the calibration MU/min to the average MU/min of
the plan. This was implemented in the simple ion recom-
bination corrections. From Table II it can be seen that the
simple corrections greatly reduce errors due to ion recom-
bination effects. There is still some difference in pass rates
between the complex and simple corrections. This is due to
the residual change in MU/min and aperture size during the
VMAT delivery. It may be possible to match the average
aperture size during calibration to that of delivery. However,
the average aperture size of the plan is not readily available
from the treatment planning system. The added complexity
of calculating aperture size may be an unrealistic burden for
clinics looking for a simple fix to ion recombination effects.
Furthermore, as MLC aperture sizes increase and more closely
resemble calibration conditions, ion recombination effects will
become more dominated by changes in MU/min. As such, it is
expected that simple corrections for MU/min will more closely
approximate complex corrections.
Choosing a calibration MU/min higher or lower than the
planned MU/min produced pass rates within 0.5%. On average
the lower MU/min calibration pass rates were closer to the
complex corrections. This is likely due to the increased collec-
tion efficiency during calibration from the lower MU/min
accounting for the increased collection efficiency from the
lower aperture size.
Many clinics use a 6 MV flattening filter free mode (6FFF)
to treat SBRT patients. The removal of the flattening filter
for 6FFF more than doubles the maximum pulse dose of the
machine. The pulse dose at the central axis of the 1000 SRS
in the Octavius 4D during calibration would increase from
0.175 mGy/pulse to approximately 0.406 mGy/pulse, which
is less than the 0.760 mGy/pulse of the 10FFF beam. The
result is that errors in pass rate due to ion recombination effects
would likely fall somewhere between the 6X and 10FFF re-
sults. However, the residual error in pass rates after the simple
corrections, shown in Table II, was similar for 6X and 10FFF.
Therefore, the residual error in 6FFF measurements would be
expected to follow the same trend.
The discussion of the ion recombination effects relies on
the accuracy of the ion recombination corrections, which
use measured pulse dose and pulse frequency to calculate
collection efficiencies. However, there is an error introduced
into the pulse dose corrections when calculating the measure-
ment collection efficiencies. The true pulse dose is needed
to determine accurate collection efficiencies. However, only
the measured pulse dose, which is effected by the collection
efficiency, is available leading to an inherent error in the
collection efficiency calculation. The magnitude of this effect
can be determined by (1) assuming a true pulse dose, (2)
calculating the corresponding measured pulse dose, (3) using
Eq. (2) to recalculate true pulse dose from the measured,
and (4) finally comparing the result to the original assumed
true pulse dose. Using this technique, the error in calculat-
ing dose from measured instead of true pulse dose in the
ion recombination corrections is less than 0.1% for all
energies.
5. CONCLUSION
1000 SRS collection efficiencies increased with decreasing
pulse dose and pulse frequency. For a given pulse dose
and a 360 Hz pulse frequency (600 and 2400 MU/min
for 6X and 10FFF, respectively), the ion recombination
was 4.44%/(mGy/pulse) and 5.01%/(mGy/pulse) for 6 MV
and 10FFF, respectively. On average, applying complex
pulse dose and pulse frequency corrections to 1000 SRS
measurements produced small changes in 6X 3D gamma pass
rates (1.17%±1.14% for 1%/1 mm gamma criteria). However,
the same corrections resulted in larger changes in pass rates for
10FFF (4.57%±3.71% for 1%/1 mm gamma criteria), which
increased when the plan contained small aperture sizes and
strict gamma criteria were used. The magnitudes of the change
in pass rates were strongly correlated to pulse frequency
(r2 = 0.96 for 6X and r2 = 0.78 for 10FFF); therefore, a
simple correction method was tested for which the MU/min of
the 1000 SRS calibration was selected to match the average
planned VMAT MU/min. On average the pass rates of the
simple corrections were within 1% of the complex correction
pass rates for all energies and gamma criteria.
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